Retraction notice to “Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer” [Gynecologic Oncology Volume 115, Issue 1, October 2009, Pages 112-120]

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/locate/withdrawalpolicy). The Editor-in-Chief of Gynecologic Oncology has retracted the following article: Douglas D. Taylor, Cicek Gercel-Taylor, Lynn P. Parker, Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer, Gynecologic Oncology, Volume 115, Issue 1, 2009, Pages 112-120, https://doi.org/10.1016/j.ygyno.2009.06.031. The article is retracted following an internal investigation by the University of Louisville and an investigation by the Office of Research Integrity (ORI) which found evidence of falsification, fabrication, and plagiarism of data. All authors have been notified of the retraction. As such this article represents a severe abuse of the scientific publishing system. The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process. RETRACTED: Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancerGynecologic OncologyVol. 115Issue 1PreviewThis article has been retracted: please see Elsevier Policy on Article Withdrawal ( https://www.elsevier.com/locate/withdrawalpolicy ). The Editor-in-Chief of Gynecologic Oncology has retracted the following article: Douglas D. Taylor, Cicek Gercel-Taylor, Lynn P. Parker, Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer, Gynecologic Oncology, Volume 115, Issue 1, 2009, Pages 112-120, https://doi.org/10.1016/j.ygyno.2009.06.031 The article is retracted following an internal investigation by the University of Louisville and an investigation by the Office of Research Integrity (ORI) which found evidence of falsification, fabrication, and plagiarism of data. Full-Text PDF